Historical record - last NADAC effective date: 4/1/2024
Product Information
DELSYM 30 MG/5 ML SUSPENSION is a brand product labeled by RB Health (US) LLC, priced at $0.1053 per ML under NDC 63824017163. Its NADAC has been published 474 times since Nov 28, 2013.
FDA first approved this application on Oct 8, 1982.
Strength
30 mg/5mL
Manufacturer
RB Health (US) LLCNDC
63824017163
Classification
Brand
Dosage Form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Effective Date
4/1/2024
Active Ingredients
DEXTROMETHORPHANApproval Type
New Drug (NDA)
FDA Application
NDA018658FDA Approved
10/8/1982
On Market Since
5/4/2010
Pharmacological Classes
Price Statistics
The NADAC for DELSYM 30 MG/5 ML SUSPENSION has been published 474 times since Nov 28, 2013, and over the history we have for it it has risen 30.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1053 per ML |
|---|---|
| All-time high | $0.1053 (Jul 3, 2024) |
| All-time low | $0.0799 (Sep 17, 2014) |
| Median price | $0.0886 |
| Average price | $0.0895 |
| Largest weekly change | +10.1% (Apr 6, 2022) |
| Weeks tracked | 474 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.0%
5Y
+13.2%
All
+30.8%
Last surveyed Jul 3, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
RB Health (US) LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DELSYM 30 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for DELSYM 30 MG/5 ML SUSPENSION, manufactured by RB Health (US) LLC, is $0.1053 per ML (NDC 63824017163), effective Jul 3, 2024.
How has the price of DELSYM 30 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for DELSYM 30 MG/5 ML SUSPENSION has risen 30.8%. It has been tracked across 474 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DELSYM 30 MG/5 ML SUSPENSION?
Since Nov 28, 2013, the NADAC for DELSYM 30 MG/5 ML SUSPENSION has ranged from a low of $0.0799 (Sep 17, 2014) to a high of $0.1053 (Jul 3, 2024), with a median of $0.0886 per ML.
Are there cheaper alternatives to DELSYM 30 MG/5 ML SUSPENSION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DELSYM 30 MG/5 ML SUSPENSION, is $0.0806 per ML — about 24% below DELSYM 30 MG/5 ML SUSPENSION.
Who manufactures DELSYM 30 MG/5 ML SUSPENSION?
DELSYM 30 MG/5 ML SUSPENSION (NDC 63824017163) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.